Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.
about
The Smart Drug Delivery System and Its Clinical PotentialNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyQuantum dots as a platform for nanoparticle drug delivery vehicle designRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingNear-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapyCholesterol-peptide hybrids to form liposome-like vesicles for gene delivery.Development of indinavir submicron lipid emulsions loaded with lipoamino acids-in vivo pharmacokinetics and brain-specific delivery.Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesDelivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomesLiposome-like Nanostructures for Drug Delivery.Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.Bone marrow-targeted liposomal carriersNanomedicine: application areas and development prospects.Recent advances in stealth coating of nanoparticle drug delivery systemsControlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery.Nanomedicine for gene therapy.Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells.The in vitro and in vivo anti-tumor effects of MTX-Fe3O 4-PLLA-PEG-PLLA microspheres prepared by suspension-enhanced dispersion by supercritical CO2.Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery.Enhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transport.Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.Light-Triggerable Liposomes for Enhanced Endolysosomal Escape and Gene Silencing in PC12 Cells.pH-Responsive single walled carbon nanotube dispersion for target specific release of doxorubicin to cancer cells.Zwitterionic sulfobetaine lipids that form vesicles with salt-dependent thermotropic properties.pH-Responsive self-assembly of cationic surfactants with a star-shaped tetra-carboxylate acid and the solubilization of hydrophobic drugs.Inducible release of particulates from liposomes using the mechanosensitive channel of large conductance and L-α-lysophosphatidylcholine.Hollow chitosan–silica nanospheres for doxorubicin delivery to cancer cells with enhanced antitumor effect in vivoNanoparticles Escaping RES and Endosome: Challenges for siRNA Delivery for Cancer Therapy
P2860
Q26744837-B5FA9472-EE4A-4C52-A4E0-98C4BE3574BEQ26858849-E802E4DF-F41D-4F8D-A19E-C6D81E3E3E1CQ26996556-B68690A8-668D-4768-937F-6CF315C8CAF7Q30456053-5A8F99FA-912A-4440-B619-1C1ABBEDE388Q34019772-3925855B-ACEB-4923-8E25-C6729CB5B08AQ34575422-B300CAA8-84C1-4947-B130-85D46430FA41Q34733900-AFCE9D93-BDB3-4A33-9EDF-3ECF5DA4790AQ35227495-2326A236-2F21-448C-82D0-823C94FBA0BBQ35605267-8EA2FE9E-0DC6-4216-8594-5B9ECBBFD1F7Q36043818-8ED2857B-CD3C-48AD-AC17-C748C5E43B7FQ36791673-30376EFC-899C-476D-B253-42178578AF89Q37232138-0F7B4E2E-5E29-4D90-9FDC-725C49D56DCCQ37424654-F7E70868-8EF6-4513-859C-2DC69FB87626Q37577552-13E136E2-4084-460B-9367-18999E275AC7Q37833107-C8D89B10-64F4-4009-8A2D-7CE12350067BQ37891690-A1D04DC2-CE91-402F-B78A-F0796142761DQ37974590-C385EFCF-2905-45ED-8FB5-1CAB286A5319Q38162492-88FD166F-2811-4158-8A49-9EF4EAC91A77Q38383478-FB53B4B7-8C17-42D7-890F-39EA7581887EQ38837880-2D1C6744-4672-46CB-A5C8-803576302062Q38984024-D6E2A67C-34DE-47F3-A735-366C16C3BC5FQ39334978-96B19B0E-E7E2-494D-9D20-161F9B38897BQ40520681-94B774FC-6D3C-40FE-8E7A-C5FED9621442Q41587732-C992951F-74B8-4C73-8390-54BE718D82D1Q41822449-587D2300-D59A-4114-AFC5-0BC6102407D4Q42795760-5376D9F3-A15E-4A47-AE3F-E8A0D863751CQ46065758-CDD9E1A3-033A-4A0A-BC57-52C9BD500E0CQ50079195-10379B03-6691-4243-896E-609D7D638E45Q54264991-AC657B95-82AA-4124-AA9D-2230E7243DBAQ57376374-3435E444-711A-49CA-A0D1-95E189876258Q58691112-CB37C735-FE34-4442-8640-3AC2FC4A2D0E
P2860
Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@en
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@nl
type
label
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@en
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@nl
prefLabel
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@en
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@nl
P2093
P1476
Evaluation of pH-responsive li ...... delivery in vitro and in vivo.
@en
P2093
Shinji Takeoka
Shoji Tajima
Yosuke Obata
P304
P356
10.1016/J.JCONREL.2009.10.023
P407
P577
2009-10-25T00:00:00Z